FDA Investigator Charles I Ann

Charles I Ann has conducted inspections on 74 sites in 10 countries as of 07 Jun 2011. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
74
Last Inspection Date:
07 Jun 2011
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
Japan, China, Sweden, Korea (Republic of), United States of America, Taiwan, India, Germany, Singapore, Switzerland
FDA Investigators that have inspected at least one site in common with Charles I Ann:
Ademola O Daramola, Alberto A Viciedo, Alice S Tsao, Amy N Chen, Anastasia G Lolas, Anderson, Andrace L Deyampert, Andrea D Swingle, Andrew B Bevill, Angela E Glenn, Anjali Shukla, PhD, Ann Marie Montemurro, Anna Lazar, Anthony M Criscuolo, Jr, Ariel Cruz Figueroa, Arsen Karapetyan, Atul J Agrawal, Azza Talaat, Barbara J Rincon, Barbara M Frazier, Bei Y He, Benjamin J Smith, Bijoy Panicker, Bonita S Chester, Brandon C Heitmeier, Brenda W Uratani, PhD, Brentley S Collins, Bruce H Mccullough, Byungja E Marciante, Carl A Anderson, Carl A Huffman, III, Carl Lee, Carla J Lundi, Caryn M Mcnab, Catherine J Laufmann, Catherine V Quinlan, Charles L Larson, Charles L Zhou, Charles M Edwards, Cheryl A Clausen, Chiang Syin, PhD, Christian D Lynch (CDL), Christina A Miller, Christina N Maurino, Christopher S Keating, Christopher T Middendorf, Constantin Y Philopoulos, Corrine M Carter, Cynthia A Harris, MD, RN, Cynthia J Lee, MS, Cynthia Jim, CSO, Cynthia M Goudeau, Danial S Hutchison, Daniel J Brown, Daniel J Mechenbier, Darren S Morgan, David A Paterson, David J Gasparovich, David M Beltran, Dawn C Olenjack, Debara R Reese, Debara Reese, Dell S Moller, Denise L Burosh, Dennis Cantellops Paite, Dennis E Guilfoyle, PhD, Diane L Raccasi, Dina A Tallman, Dipesh K Shah, Dolores Harper, Don H Bark, PhD, Donald C Obenhuber, PhD, Donna Ltartaglino Besone, Dr. Gang Wang, PhD, Dr. Guang Gao, PhD, Dr. Jason R Caballero, Dr. Robert C Horan, MD, Dr. Zhihao Qiu (Peter), PhD, Edmund F Mrak, Jr, Edwin Martinez, Edwin Melendez, Eliezar Ramos, Elizabeth M Jacobson, Emest F Bizjak, Emily J Orban, Eric Rothschild, Erica L Nicoll, Evelyn Taha, Farhana Khan, Felix Maldonado, Frederick F Razzaghi, Gam S Zamil, Gene D Arcy, Geneve M Maxwell, Geneve M Parks, George J Flynn, Gregson A Joseph, Gwyn G Dickinson, Helen B Ricalde, Ivis L Negron, Jacob G Lutz, Jacqueline Mdiaz Albertini, James C Maclaughlin, James K Ireland, James P Mcreavey, James R Birkenstamm, Jane S Wernberg, Janet L Bowen, Javier O Vega, Jawaid Hamid, Jean Blackston Hill, Jeffrey A Sommers, Jeffrey D Meng, Jennifer A Kemp, Jennifer Lalama, Jennifer M Gogley, Jessica Chery, Joey V Quitania, John A Gonzalez, John A Sciacchitano, John L Stevens, Jonah S Ufferfilge, Jonathan G Matrisciano, Jose A Lopez, Jose Acruz Gonzalez, José E Meléndez, Jose R Hernandez, Joseph A Piechocki, Joseph R Strelnik, Joshua P Wireman, Julie D Bringger, June P Page, Junho Pak, Justin A Boyd, Kalavati Suvarna, PhD, Karen M Montgomery (KMM), Kari M Johansen, Kari M Laynor, Katherine E Jacobitz, Katherine Szestypalow, Kathleen R Jones, PhD, Katie L Penno, Kelvin Cheung, Kelvin X Sanders, Kent C Faul, Kevin D Kallander, Kham Phommachanh, Kim Lthomas Cruse, Kirtida Patel, Kshitij A Patkar, Kula N Jha, L'oreal F Walker, Laishan L Lam, Larry K Austin, Lauren Iacono Connors, PhD, LCDR Debra Emerson, Leigh Anne Myers, Lequita M Mayhew, Leslie A Paul, Linda F Murphy, Linda M Cheny, Linda Thai, Lindsey M Schwierjohann, Lisa M Bellows, Lisa R Jennings, Lisa R Whitt, Lloyd D Payne, Luella J Rossi, Luis A Dasta, Luis Mburgos Medero, Marcelo O Mangalindan, Jr, Marcus F Yambot, Margaret M Annes, Marie F Morin, Marijo B Kambere, PhD, Marjorie D Schultz, Mark R Mcclain, Martha Sullivan Myrick, Mary E Storch, Maryam Tabatabaie, Matthew B Casale, Matthew J Gretkierewicz, Maxwell Van Tassell, PhD, Mei Chiung Huang (Jo), Meisha R Sampson, Meisha Waters, Melina Lrodriguez Upton, Mercy Oyugi, Michael A Charles, Michael D Garcia, Michael R Goga, Michael R Klapal, Michael Shanks, MS, Michele L Forster, PhD, Michele L Obert, Michele Perry Williams, Miguel A Martinez Perez, Mihaly S Ligmond, Minh D Phan, Montgomery Montgomery, Karen M, Mra Davism, Mra Mcculloughj, Mra Munizn, Muna Algharibeh, Myra K Casey, Nailing Zhang, Neali H Lucas, Nicholas A Violand, Nicole A Lloyd, Norman Wong, Omotunde O Osunsanmi, Pal S Mayasandra, Parul M Patel, Patricia A Cochran, Patricia F Hughes, PhD, Patricia H Dlugosz, Patrick B Cummings, Patrick C Klotzbuecher, Patsy J Domingo, Patty P Kaewussdangkul, Paul L Bellamy, Paula A Trost, Paula J Perry, Perry H Gambrell, Peter E Baker, Peter R Lenahan, Philip A Klimkewicz, Philip F Istafanos, DMV, MS, Prabhu P Raju, Pratik S Upadhyay, DDC, Qiao Y Bobo, Qin Xu, Rafael E Arroyo, Rafeeq A Habeeb, Rajiv R Srivastava, Ralph A Erickson, Ramesh Potla, PhD, Ramon A Hernandez, Randy L Self, Raymond Kent, Raymond R Roy, PhD, Raymond T Oji, Rebecca E Dombrowski, Rebecca Rodriguez, Regina T Brown, Remache, Richard W Tubb, Robert C Coleman, Robert D Tollefsen, Robert J Ham, Robert J Martin, Robert M Barbosa, Robert P Whisenant, Robert R Barbosa, Robin P Mathew, Ronald G Crawford, Rory K Geyer, Rumany C Penn, PharmD, Samuel T Walker, Sandra A Boyd, Sandra A Hughes, Sanket N Patel, Sarah E Rhoades, Sarah M Napier, Sarah Rhoades, Scott A Golladay, Scott T Ballard, Seneca D Toms, Sharon K Thoma, PharmD, Shawn E Larson, Shawn R Gould, Sherri J Liu, Shirley H Isbill, Sidney B Priesmeyer, Simone E Pitts, Sixto M Mercado Rios, Sony Mathews, Stephanie A Slater, MS, Stephen D Brown, Stephen J Mottola, Steven C Madzo, Steven D Kehoe, Susan F Laska, MS, Susan M Jackson, Susan P Bruederle, Susan W Ting, Suyang Qin, Tamala P Bogan, Tamala P Magee, Tamara M Kays, Thomas A Peter, Thomas E Friel, Thomas J Arista, Thomas J Cosgrove, Thuy T Nguyen, LCDR, Timothy T Kapsala, Tina M Pawlowski, Tonnie L Carter, Tony T Yang, Torrance J Slayton, Tracey Asinjen Wiersma, Tracey L Harris, Travis R Hunt, Travis S Bradley, Tricia S Martinez, Tricia Y Samaniego, Trudy R Papson, Truong Xuan Nguyen (Andy), Twana R Chandler, Unnee Ranjan, Uttaniti Limchumroon (Tom), Vioela J Caze, Viviana Matta, Vlada Matusovsky, Wayne E Seifert, Wayne T Smith, William D Tingley, Xiaokuang Lai, PhD, Yangmin Ning, Yanming An, PhD, Yasamin Ameri, Yumi J Hiramine, Yvette I Johnson, Yvins Dezan, Yvonne E Lozano, Zachary A Bogorad, Zachary L Stamm, Zhong Li, PhD, Zhongren Wu, Zi Qiang Gu

Charles I Ann's Documents

Publish Date Document Type Title
June, 2004 FDA 483 Merck KGaA - Form 483, 2004-06-16
February, 2002 FDA 483 Pharmacia & Upjohn AB - Form 483, 2002-02-20
February, 2000 FDA 483 Response Dr Reddy's Laboratories Limited - Form 483R, 2000-04-07
January, 2001 EIR CKD BIO Corp. Ansan Factory - EIR, 2001-04-03
August, 2001 FDA 483 Response Asahi Vet Japan Co., Ltd - Form 483R, 2001-09-07
February, 2000 EIR Dr Reddy's Laboratories Limited - EIR, 2004-07-01
August, 2001 EIR Asahi Vet Japan Co., Ltd - EIR, 2001-08-10
February, 2002 FDA 483 Pfizer Health AB - Form 483, 2002-02-25
December, 2002 FDA 483 Lee & Company - Form 483, 2002-12-13
February, 2000 FDA 483 Response LUPIN LIMITED - Form 483R, 2000-03-01
August, 2001 EIR Asahi Kasei Medical MT Corp. Oita Works - EIR, 2001-08-10
May, 2002 EIR Eli Lilly and Company - EIR, 2002-05-30
April, 2000 EIR Constant Irwindale Inc. - EIR, 2000-04-28
January, 2001 FDA 483 CKD BIO Corp. Ansan Factory - Form 483, 2001-01-17
February, 2002 FDA 483 Response Pfizer Health AB - Form 483R, 2002-03-15
August, 2001 FDA 483 Asahi Vet Japan Co., Ltd - Form 483, 2001-08-09
May, 2002 FDA 483 Eli Lilly and Company - Form 483, 2002-05-30
January, 2001 EIR Sankyo Co., Ltd. - EIR, 2001-04-03
September, 2002 EIR MSD International GmbH (Singapore Branch) - EIR, 2002-09-19
February, 2002 EIR Pfizer Health AB - EIR, 2002-02-25
June, 2004 EIR Merck KGaA - EIR, 2004-08-11
January, 2001 FDA 483 Response CKD BIO Corp. Ansan Factory - Form 483R, 2001-02-09
February, 2000 FDA 483 Dr Reddy's Laboratories Limited - Form 483, 2000-02-25
February, 2000 FDA 483 Lupin Laboratories Limited, Mandideep - Form 483, 2000-02-17
June, 2000 EIR Pharmacia & Upjohn Company LLC - EIR, 2000-06-28
June, 2000 FDA 483 Pharmacia & Upjohn Company LLC - Form 483, 2000-06-28
August, 2001 FDA 483 Response Asahi Kasei Medical MT Corp. Oita Works - Form 483R, 2001-09-07
February, 2000 EIR LUPIN LIMITED - EIR, 2000-06-29
May, 2001 EIR Novartis Pharma AG - EIR, 2001-05-10
March, 2009 FDA 483 Tai Heng Industry Co., Ltd. - Form 483, 2009-03-06
June, 2004 FDA 483 Response Merck KGaA - Form 483R, 2004-06-30
August, 2001 FDA 483 Joko Pharmaceutical Co., Ltd. - Form 483, 2001-08-03
June, 2000 FDA 483 Response Pharmacia & Upjohn Company LLC - Form 483R, 2000-07-14
May, 2002 FDA 483 Response Eli Lilly and Company - Form 483R, 2002-05-30

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more